Medivolve Announces Change of Auditor
Medivolve Announces Change of Auditor
TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP ("MNP") to MS Partners LLP ("MS Partners"), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 ("NI 51‐102"), the Company has filed a Change of Auditor Notice on SEDAR+ together with letters from both MNP and MS Partners, with each letter confirming agreement with the statements contained in the notice, as applicable. There were no reportable events (as defined in NI 51‐102) between MNP and the Company.
多伦多，2024年2月12日（GLOBE NEWSWIRE）——Medivolve Inc.（“Medivolve” 或 “公司”）（Cboe CA：MEDV；场外交易所：MDVF；FRA: 4NC）宣布，已将审计师从MNP LLP（“MNP”）改为MS Partners LLP（“MS Partners”），自2024年2月6日起生效。MNP自2024年1月16日生效之日起辞职，MS Partners被任命为继任审计师。根据National Instrument 51‐102（“NI 51‐102”），公司已就SEDAR+提交了审计员变更通知以及MNP和MS Partners的信函，每封信都确认同意通知中包含的声明（如适用）。MNP与公司之间没有发生任何应报告的事件（定义见NI 51‐102）。
About Medivolve
关于 Medivolve
Medivolve is a Canadian healthcare technology company headquartered in Toronto, Canada. The Company's mission is to improve health and lives by delivering world-class diagnostic solutions—starting with COVID-19—as well as to enable faster and better care to patients through innovative technology. Medivolve, through its subsidiaries, operates retail patient-care locations in California.
Medivolve是一家加拿大医疗保健技术公司，总部位于加拿大多伦多。该公司的使命是通过提供世界一流的诊断解决方案（从COVID-19开始）来改善健康和生活，并通过创新技术为患者提供更快、更好的护理。Medivolve通过其子公司在加利福尼亚州经营零售患者护理场所。
For investing inquiries, please contact: David Preiner, CEO, info@medivolve.ca, 702-990-3737.
如需投资咨询，请联系：首席执行官大卫·普雷纳，info@medivolve.ca，702-990-3737。